🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy of two doses of subling...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00674700
The purpose of this study is to determine the efficacy and safety of three ...
Status
Completed
Location
National University Hospital - Allergy Unit 4222
Start Date
2008-10
Trial ID
NCT00901914
The trial aims to demonstrate efficacy of the House Dust Mite SLIT-tablet v...
Status
Completed
Location
Miami Clinical Research
Start Date
2018-02-22
Trial ID
NCT03654976
Treatments Being Tested
A phase III study to evaluate Long term efficacy , carry-over effect and sa...
Status
Completed
Location
DIDIER
Start Date
2006-12
Trial ID
NCT00418379
Treatments Being Tested
A research study of how house dust mite tablets work compared to placebo in...
Status
Completed
Location
Allergy & Asthma Specialists Medical Group and Research Center
Start Date
2019-10-12
Trial ID
NCT04145219
Treatments Being Tested
A phase III study to evaluate the efficacy and safety of SLIT for grass pol...
Status
Completed
Location
Charité - Campus Virchow Klinikum
Start Date
2006-12
Trial ID
NCT00409409
Treatments Being Tested
This clinical research study investigates the safety, tolerability and effi...
Status
Completed
Location
Arkansas Children's Hospital
Start Date
2022-09-07
Trial ID
NCT05440643
Treatments Being Tested
To evaluate the safety and efficacy of SLIT compared with placebo for reduc...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00367640
The primary objective of this study is to assess whether the combination of...
Status
Completed
Location
Royal Brompton Hospital
Start Date
2020-11-05
Trial ID
NCT04502966
Treatments Being Tested
To investigate the immunologic effects and safety of 60-day treatment of th...
Status
Completed
Location
Research facility ID ORG-001086
Start Date
2014-10
Trial ID
NCT02245360
Treatments Being Tested